Filing Details

Accession Number:
0001209191-19-005357
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-01-25 16:40:50
Reporting Period:
2019-01-23
Accepted Time:
2019-01-25 16:40:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1108205 Curis Inc CRIS Biological Products, (No Disgnostic Substances) (2836) 043505116
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1400977 E James Dentzer C/o Curis, Inc.
4 Maguire Road
Lexington MA 02421
President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-01-23 2,397 $1.09 44,733 No 4 S Direct
Common Stock Disposition 2019-01-24 3,094 $1.16 41,639 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. These transactions were effected pursuant to Rule 10b5-1 trading plans to cover tax obligations.
  2. On May 29, 2018, the Company effected a 1-for-5 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.
  3. The price reported in Column 4 is a weighted average price for the shares sold. These shares were sold in multiple transactions at prices ranging from $1.15 to $1.17, inclusive. The reporting person undertakes to provide to Curis, Inc., any security holder of Curis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth on this Form 4.